Kazia Therapeutics (KZIA) Assets (2009 - 2025)

Kazia Therapeutics (KZIA) has 14 years of Assets data on file, last reported at $46.7 million in Q4 2025.

• In Q4 2025, Assets rose 298.6% year-over-year to $46.7 million; the TTM figure through Dec 2025 stood at $46.7 million (up 298.6% YoY), while the FY2025 annual figure was $3.9 million, down 72.72% from the prior year.
• Assets rose to $46.7 million in Q4 2025, from $3.9 million in the prior quarter.
• Across five years, Assets topped out at $46.7 million in Q4 2025 and bottomed at $3.9 million in Q2 2025.
• A 5-year average of $22.1 million and a median of $18.3 million in 2022 frame the typical range for Assets.
• The widest YoY moves for Assets: up 298.6% in 2025, down 72.72% in 2025.
• Year by year, Assets stood at $44.7 million in 2021, then sank by 59.11% to $18.3 million in 2022, then dropped by 13.21% to $15.9 million in 2023, then declined by 26.21% to $11.7 million in 2024, then soared by 298.6% to $46.7 million in 2025.
• The last three Assets figures came in at $46.7 million (Q4 2025), $3.9 million (Q2 2025), and $11.7 million (Q4 2024), per Business Quant data.

Peer Comparison